331 related articles for article (PubMed ID: 11907489)
21. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata.
Behrens-Williams SC; Leiter U; Schiener R; Weidmann M; Peter RU; Kerscher M
J Am Acad Dermatol; 2001 Feb; 44(2):248-52. PubMed ID: 11174382
[TBL] [Abstract][Full Text] [Related]
22. [Differentiation of the antipsoriatic and phototoxic effectiveness of topical PUVA therapy].
Meffert H; Rowe E; Miehe M; Sönnichsen N
Hautarzt; 1986 Feb; 37(2):90-3. PubMed ID: 3957667
[TBL] [Abstract][Full Text] [Related]
23. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
Shephard SE; Panizzon RG
Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
[TBL] [Abstract][Full Text] [Related]
24. Comparison of skin concentrations following topical versus oral corticosteroid treatment: reconsidering the treatment of common inflammatory dermatoses.
McClain RW; Yentzer BA; Feldman SR
J Drugs Dermatol; 2009 Dec; 8(12):1076-9. PubMed ID: 20027934
[TBL] [Abstract][Full Text] [Related]
25. Plasma levels of 8-methoxypsoralen following oral or bath-water treatment.
Thomas SE; O'Sullivan J; Balac N
Br J Dermatol; 1991 Jul; 125(1):56-8. PubMed ID: 1873204
[TBL] [Abstract][Full Text] [Related]
26. Plasma levels of 8-methoxypsoralen after topical paint PUVA.
Pham CT; Koo JY
J Am Acad Dermatol; 1993 Mar; 28(3):460-6. PubMed ID: 8445063
[TBL] [Abstract][Full Text] [Related]
27. High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.
Kappes UP; Barta U; Merkel U; Balogh A; Elsner P
Skin Pharmacol Appl Skin Physiol; 2003; 16(5):305-12. PubMed ID: 12907835
[TBL] [Abstract][Full Text] [Related]
28. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen.
Koulu L; Jansén CT
Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328
[TBL] [Abstract][Full Text] [Related]
29. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
Collins P; Rogers S
Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
[TBL] [Abstract][Full Text] [Related]
30. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
[TBL] [Abstract][Full Text] [Related]
31. Long-term efficacy of PUVA treatment in lichen planus: comparison of oral and external methoxsalen regimens.
Helander I; Jansén CT; Meurman L
Photodermatol; 1987 Oct; 4(5):265-8. PubMed ID: 3697349
[TBL] [Abstract][Full Text] [Related]
32. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
Bech-Thomsen N; Angelo HR; Wulf HC
Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
[TBL] [Abstract][Full Text] [Related]
33. Phototoxicity and antipsoriatic effect of a topical methoxypsoralen solution in relation to the application time.
Meffert H; Andersen KE; Sönnichsen N
Photodermatol; 1984 Aug; 1(4):191-4. PubMed ID: 6531293
[TBL] [Abstract][Full Text] [Related]
34. Variation in 8-methoxypsoralen profiles during long-term psoralen plus ultraviolet A therapy and correlations between serum 8-methoxypsoralen levels and chromametric parameters.
Marrakchi S; Decloquement L; Pollet P; Briand G; Loesche C; Bocquet JL; Degand P; Thomas P
Photodermatol Photoimmunol Photomed; 1991 Oct; 8(5):206-11. PubMed ID: 1822684
[TBL] [Abstract][Full Text] [Related]
35. [Influence of retinoids on the bioavailability of methoxy-8-psoralen].
Beani JC; Bonnot D; Berthod F; Boitard M; Reymond JL; Beriel H; Amblard P
Ann Dermatol Venereol; 1991; 118(4):273-5. PubMed ID: 2069337
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
[TBL] [Abstract][Full Text] [Related]
37. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
Schempp CM; Schöpf E; Simon JC
Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
[TBL] [Abstract][Full Text] [Related]
38. Plasma levels of 8-methoxypsoralen following PUVA-bath photochemotherapy.
von Kobyletzki G; Hoffmann K; Kerscher M; Altmeyer P
Photodermatol Photoimmunol Photomed; 1998; 14(3-4):136-8. PubMed ID: 9779504
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic comparison of seven 8-methoxypsoralen brands.
Menne T; Andersen KE; Larsen E; Solgaard P
Acta Derm Venereol; 1981; 61(2):137-40. PubMed ID: 6165189
[TBL] [Abstract][Full Text] [Related]
40. Comparison of tissue and plasma levels of ibuprofen after oral and topical administration.
Dominkus M; Nicolakis M; Kotz R; Wilkinson FE; Kaiser RR; Chlud K
Arzneimittelforschung; 1996 Dec; 46(12):1138-43. PubMed ID: 9006788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]